Fulcrum Therapeutics, Inc.: Fulcrum Therapeutics Announces Recent Business Highlights and ...
On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 ...
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth ...
On track to provide clinical data from the 12 mg dose cohort from the Phase 1b PIONEER trial of pociredir in SCD in mid-2025 and the 20 mg dose cohort by the end of 2025 ― ― Ended 2024 with $241.0 ...